Patent · US Active

Drug delivery through hydrogel plugs

US8409606B2 · kind B2 · utility

48Cited by
335References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 12, 2010
Grant dateApr 2, 2013
Priority date
Expiry dateMay 14, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61F2250/0067
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An embodiment is a medical prosthesis for blocking or reducing tear flow through a punctum or canaliculus of a human eye and delivering a drug to the eye that comprises a dehydrated covalently crosslinked synthetic hydrophilic polymer hydrogel with dimensions to pass through a puncta lacrimali, with the dehydrated hydrogel absorbing physiological water to swell to at least 1 mm in cross-sectional width and conformably fit a canaliculus, with the hydrogel comprising a therapeutic agent dispersed through the hydrogel for release to an eye, with the hydrogel having a water content of at least about 50% by weight or volume when allowed to fully hydrate in vitro in physiological saline.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.